Biosimilars: Is Imitation the Sincerest Form of Clinical Efficacy?

This recording of our program from April 2024 features Dr Marc Carrier and pharmacist Ryan Kerzner. They discuss a number of topics around biosimilars and LMWH biosimilars in particular.
At the end of this program, they aim to help participants to be better able to:
Describe at a high level how evidence for biosimilars is assessed by regulatory agencies in Canada
Discuss criteria in evaluating/choosing biosimilar low molecular weight heparin (LMWH) agents
Provide effective education on biosimilars to patients
The program covers a number of questions that are frequently asked about these recently introduced products.